← Back to Search

Dietary Supplement

1 for Osteoarthritis

N/A
Waitlist Available
Led By Ezra Kwok, Dr
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

Osteoarthritis (OA) is the most common joint disease associated with aging. Although many patients take glucosamine supplements as a non-traditional treatment for osteoarthritis, the effectiveness of these supplements is questionable. This study will evaluate glucosamine therapy by directly analyzing two functions of joint fluid that are impaired by osteoarthritis - namely, the abilities to lubricate the joint and absorb shocks during activity. Joint fluid samples will be collected from subjects with knee osteoarthritis and analyzed on a device that simulates typical joint movements. After 3 months of glucosamine supplementation, samples will be collected again to detect potential improvements in joint fluid function.

Eligible Conditions
  • Osteoarthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in synovial fluid viscosity and viscoelasticity compared to baseline
Secondary outcome measures
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) total score

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: 1Experimental Treatment1 Intervention
Glucosamine sulphate tablets
Group II: 2Placebo Group1 Intervention
Placebo tablets
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Glucosamine sulphate
2006
Completed Phase 4
~250

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,413 Previous Clinical Trials
2,466,941 Total Patients Enrolled
26 Trials studying Osteoarthritis
1,947 Patients Enrolled for Osteoarthritis
Christie Newton, Dr.Study DirectorUniversity of British Columbia
Ezra Kwok, DrPrincipal InvestigatorUniversity of British Columbia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby Apr 2025